These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 9352392)

  • 21. Skipping a pillar does not make for strong foundations: Pharmacokinetic-pharmacodynamic reasoning behind the shape of dose-response relationships in oncology.
    Yates JWT; Mistry HB
    CPT Pharmacometrics Syst Pharmacol; 2023 Nov; 12(11):1591-1601. PubMed ID: 37771203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pattern Recognition in Pharmacodynamic Data Analysis.
    Gabrielsson J; Hjorth S
    AAPS J; 2016 Jan; 18(1):64-91. PubMed ID: 26542613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacodynamic and pharmacokinetic properties of an angiotensin II receptor antagonist--characterization by use of Schild regression technique in man.
    Breithaupt-Grögler K; Malerczyk C; Belz GG; Butzer R; Herrmann V; Stass H; Wensing G
    Int J Clin Pharmacol Ther; 1997 Oct; 35(10):434-41. PubMed ID: 9352392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin II dose-effect curves and Schild regression plots for characterization of different angiotensin II AT1 receptor antagonists in clinical pharmacology.
    Belz GG
    Br J Clin Pharmacol; 2003 Jul; 56(1):3-10. PubMed ID: 12848769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical pharmacology of lacidipine.
    Hall ST; Harding SM; Evans GL; Pellegatti M; Rizzini P
    J Cardiovasc Pharmacol; 1991; 17 Suppl 4():S9-13. PubMed ID: 1726014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concentration-effect analysis of antihypertensive drug response. Focus on calcium antagonists.
    Donnelly R; Elliott HL; Meredith PA
    Clin Pharmacokinet; 1994 Jun; 26(6):472-85. PubMed ID: 8070220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Schild regression in the process of receptor classification.
    Kenakin TP
    Can J Physiol Pharmacol; 1982 Mar; 60(3):249-65. PubMed ID: 7042056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose-Response-Time Data Analysis: An Underexploited Trinity.
    Gabrielsson J; Andersson R; Jirstrand M; Hjorth S
    Pharmacol Rev; 2019 Jan; 71(1):89-122. PubMed ID: 30587536
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 30.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 31.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.